BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 23025384)

  • 1. Effect of microplasmin on the clearance of vitreous haemorrhage from an experimental model in rabbits.
    Gad Elkareem AM; de Smet MD
    Acta Ophthalmol; 2014 Feb; 92(1):47-50. PubMed ID: 23025384
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microplasmin-induced posterior vitreous detachment affects vitreous oxygen levels.
    Quiram PA; Leverenz VR; Baker RM; Dang L; Giblin FJ; Trese MT
    Retina; 2007 Oct; 27(8):1090-6. PubMed ID: 18040251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety of in vivo pharmacologic vitreolysis with recombinant microplasmin in rabbit eyes.
    Sakuma T; Tanaka M; Mizota A; Inoue J; Pakola S
    Invest Ophthalmol Vis Sci; 2005 Sep; 46(9):3295-9. PubMed ID: 16123432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Microplasmin: a novel thrombolytic that improves behavioral outcome after embolic strokes in rabbits.
    Lapchak PA; Araujo DM; Pakola S; Song D; Wei J; Zivin JA
    Stroke; 2002 Sep; 33(9):2279-84. PubMed ID: 12215599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Posterior vitreous detachment induced by microplasmin.
    Gandorfer A; Rohleder M; Sethi C; Eckle D; Welge-Lüssen U; Kampik A; Luthert P; Charteris D
    Invest Ophthalmol Vis Sci; 2004 Feb; 45(2):641-7. PubMed ID: 14744909
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [An experimental study on dissolving and detaching vitreoretinal interface with enzymes].
    Wang LF; Ma JX; Liu JZ; Cai SZ; Lu LC; Wang ZD
    Zhonghua Yan Ke Za Zhi; 2004 Jul; 40(7):459-64. PubMed ID: 15454060
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enzyme-induced posterior vitreous detachment in the rat produces increased lens nuclear pO2 levels.
    Giblin FJ; Quiram PA; Leverenz VR; Baker RM; Dang L; Trese MT
    Exp Eye Res; 2009 Feb; 88(2):286-92. PubMed ID: 18835558
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Characterization of a stabilized form of microplasmin for the induction of posterior vitreous detachment.
    Gad Elkareem AM; Willekens B; Vanhove M; Noppen B; Stassen JM; de Smet MD
    Curr Eye Res; 2010 Oct; 35(10):909-15. PubMed ID: 20858112
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microplasmin: ex vivo characterization of its activity in porcine vitreous.
    de Smet MD; Valmaggia C; Zarranz-Ventura J; Willekens B
    Invest Ophthalmol Vis Sci; 2009 Feb; 50(2):814-9. PubMed ID: 18806295
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enzymatic vitreous disruption.
    Gandorfer A
    Eye (Lond); 2008 Oct; 22(10):1273-7. PubMed ID: 18292784
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential vitreous dye diffusion following microplasmin or plasmin pre-treatment.
    Gad Elkareem AM; Willikens B; Stassen JM; de Smet MD
    Curr Eye Res; 2010 Mar; 35(3):235-41. PubMed ID: 20373883
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental evaluation of microplasmin - an alternative to vital dyes.
    Gandorfer A
    Dev Ophthalmol; 2008; 42():153-159. PubMed ID: 18535388
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hyaluronidase (Vitrase)--ISTA: hyaluronidase--ISTA pharmaceuticals.
    Drugs R D; 2003; 4(3):194-7. PubMed ID: 12757408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. PVD following plasmin but not hyaluronidase: implications for combination pharmacologic vitreolysis therapy.
    Wang ZL; Zhang X; Xu X; Sun XD; Wang F
    Retina; 2005 Jan; 25(1):38-43. PubMed ID: 15655439
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Safety results of two phase III trials of an intravitreous injection of highly purified ovine hyaluronidase (Vitrase) for the management of vitreous hemorrhage.
    Kuppermann BD; Thomas EL; de Smet MD; Grillone LR;
    Am J Ophthalmol; 2005 Oct; 140(4):585-97. PubMed ID: 16226510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel human microplasmin fold: new perspective to thrombosis treatment.
    Joison AN; Gallo FS
    Blood Coagul Fibrinolysis; 2011 Apr; 22(3):236-9. PubMed ID: 21245749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of microplasmin on recovery in a rat embolic stroke model.
    Rasmussen RS; Overgaard K; Pakola S; Boysen G
    Neurol Res; 2008 Feb; 30(1):75-81. PubMed ID: 17588313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repetitive, low-dose tissue plasminogen activator for clearance of experimental vitreous hemorrhage.
    Zhao P; Wang W; Song H; Zhu Y
    Yan Ke Xue Bao; 1995 Mar; 11(1):29-31, 40. PubMed ID: 8575602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A placebo-controlled trial of microplasmin intravitreous injection to facilitate posterior vitreous detachment before vitrectomy.
    Benz MS; Packo KH; Gonzalez V; Pakola S; Bezner D; Haller JA; Schwartz SD
    Ophthalmology; 2010 Apr; 117(4):791-7. PubMed ID: 20138368
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental induction of posterior vitreous detachment in rabbits with hyaluronidase and perfluoroethane (C2F6)].
    Shen LP; Wang JY; Huang ZM
    Zhejiang Da Xue Xue Bao Yi Xue Ban; 2004 Jul; 33(4):335-9. PubMed ID: 15269986
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.